Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Boston Scientific Corp (BSX)
since 2015 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Boston Scientific Corp.
(See page 1 of this report.) Table 2 shows the detailed insider transactions.
This company's CIK number is 885725.
Total stock buying since 2015: $9,656,193.
Total stock sales since 2015: $529,079,619.
Total stock option exercises since 2015: $72,235,199.
Table 3. Detailed insider trading at Boston Scientific Corp (BSX) , Part 8
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2017-06-02 | Pierce David A (SVP and President, Endoscopy) | Sale | 2,972 | 27.70 | 82,312 |
| 2017-06-01 | Butcher Arthur C (SVP&Pres, Endoscopy) | Option Ex | 1,761 | .00 | 0 |
| 2017-06-01 | Pierce David A (SVP and President, Endoscopy) | Option Ex | 2,972 | .00 | 0 |
| 2017-06-01 | Pratt Timothy A. (EVP, GC & Chief Admin Officer) | Sale | 10,000 | 27.13 | 271,260 |
| 2017-05-30 | Phalen Michael P. (EVP & President, MedSurg) | Sale | 15,500 | 27.25 | 422,375 |
| 2017-05-30 | Phalen Michael P. (EVP & President, MedSurg) | Option Ex | 15,500 | 7.16 | 110,980 |
| 2017-05-17 | Ballinger Kevin J. (EVP & Pres, Interven Cardio) | Sale | 28,864 | 26.13 | 754,302 |
| 2017-05-01 | Phalen Michael P. (EVP & President, MedSurg) | Sale | 15,500 | 26.37 | 408,781 |
| 2017-05-01 | Phalen Michael P. (EVP & President, MedSurg) | Option Ex | 15,500 | 7.16 | 110,980 |
| 2017-05-01 | Pratt Timothy A. (EVP, GC & Chief Admin Officer) | Sale | 10,000 | 26.37 | 263,730 |
| 2017-04-26 | Pierce David A (SVP and President, Endoscopy) | Sale | 10,250 | 26.00 | 266,500 |
| 2017-04-26 | Pierce David A (SVP and President, Endoscopy) | Option Ex | 10,250 | 7.39 | 75,747 |
| 2017-04-26 | Phalen Michael P. (EVP & President, MedSurg) | Sale | 34,773 | 26.00 | 904,098 |
| 2017-04-26 | Phalen Michael P. (EVP & President, MedSurg) | Option Ex | 34,773 | 12.52 | 435,357 |
| 2017-04-24 | Sununu John E (Director) | Buy | 29 | 25.52 | 740 |
| 2017-04-10 | Sorenson John Bradley (SVP, Manuf & Sup Chn) | Sale | 2,950 | 24.66 | 72,747 |
| 2017-04-03 | Pratt Timothy A. (EVP, GC & Chief Admin Officer) | Sale | 10,000 | 24.87 | 248,730 |
| 2017-03-29 | Phalen Michael P. (EVP & President, MedSurg) | Sale | 79,045 | 24.55 | 1,940,317 |
| 2017-03-29 | Phalen Michael P. (EVP & President, MedSurg) | Option Ex | 46,500 | 7.16 | 332,940 |
| 2017-03-03 | Pierce David A (SVP and President, Endoscopy) | Sale | 25,012 | 25.02 | 625,675 |
| 2017-03-03 | Pratt Timothy A. (EVP, GC & Chief Admin Officer) | Sale | 23,540 | 25.02 | 588,853 |
| 2017-03-02 | Mackey Edward F (EVP, Operations) | Option Ex | 19,226 | .00 | 0 |
| 2017-02-28 | Butcher Arthur C (SVP&Pres, Endoscopy) | Option Ex | 3,383 | .00 | 0 |
| 2017-02-28 | Thepaut Eric Francis Yves (SVP & Pres, Europe) | Option Ex | 5,413 | .00 | 0 |
| 2017-02-28 | Sorenson John Bradley (SVP, Manuf & Sup Chn) | Option Ex | 5,413 | .00 | 0 |
| 2017-02-28 | Brennan Daniel J. (EVP and CFO) | Option Ex | 2,706 | .00 | 0 |
| 2017-02-28 | Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) | Sale | 25,000 | 24.67 | 616,675 |
| 2017-02-28 | Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) | Option Ex | 3,721 | .00 | 0 |
| 2017-02-28 | Ballinger Kevin J. (EVP & Pres, Interven Cardio) | Option Ex | 5,751 | .00 | 0 |
| 2017-02-28 | Carruthers Wendy (SVP, Human Resources) | Option Ex | 3,721 | .00 | 0 |
| 2017-02-28 | Bose Supratim (EVP & President, Asia-Pacific) | Option Ex | 6,766 | .00 | 0 |
| 2017-02-28 | Mahoney Michael F (Chairman, President & CEO) | Option Ex | 50,744 | .00 | 0 |
| 2017-02-28 | Pierce David A (SVP and President, Endoscopy) | Option Ex | 4,398 | .00 | 0 |
| 2017-02-28 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 3,383 | .00 | 0 |
| 2017-02-28 | Dawkins Keith D (EVP, Global Chief Med. Off.) | Sale | 30,000 | 24.64 | 739,140 |
| 2017-02-28 | Dawkins Keith D (EVP, Global Chief Med. Off.) | Option Ex | 4,736 | .00 | 0 |
| 2017-02-28 | Fitzgerald Joseph Michael (EVP & President, CRM) | Option Ex | 6,089 | .00 | 0 |
| 2017-02-28 | Phalen Michael P. (EVP & President, MedSurg) | Option Ex | 5,413 | .00 | 0 |
| 2017-02-28 | Pratt Timothy A. (EVP, GC & Chief Admin Officer) | Option Ex | 8,457 | .00 | 0 |
| 2017-02-27 | Butcher Arthur C (SVP&Pres, Endoscopy) | Option Ex | 5,096 | .00 | 0 |
| 2017-02-27 | Thepaut Eric Francis Yves (SVP & Pres, Europe) | Option Ex | 8,600 | .00 | 0 |
| 2017-02-27 | Sorenson John Bradley (SVP, Manuf & Sup Chn) | Option Ex | 14,332 | .00 | 0 |
| 2017-02-27 | Brennan Daniel J. (EVP and CFO) | Option Ex | 5,176 | .00 | 0 |
| 2017-02-27 | Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) | Option Ex | 2,389 | .00 | 0 |
| 2017-02-27 | Ballinger Kevin J. (SVP & Pres, Interven Cardio) | Option Ex | 3,185 | .00 | 0 |
| 2017-02-27 | Carruthers Wendy (SVP, Human Resources) | Option Ex | 9,236 | .00 | 0 |
| 2017-02-27 | Bose Supratim (EVP & President, Asia-Pacific) | Option Ex | 3,185 | .00 | 0 |
| 2017-02-27 | Mahoney Michael F (Chairman, President & CEO) | Option Ex | 114,650 | .00 | 0 |
| 2017-02-27 | Pierce David A (SVP and President, Endoscopy) | Sale | 6,834 | 24.84 | 169,762 |
| 2017-02-27 | Pierce David A (SVP and President, Endoscopy) | Option Ex | 6,370 | .00 | 0 |
| 2017-02-27 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 2,389 | .00 | 0 |
| 2017-02-27 | Dawkins Keith D (EVP, Global Chief Med. Off.) | Option Ex | 4,777 | .00 | 0 |
| 2017-02-27 | Fitzgerald Joseph Michael (EVP & President, CRM) | Option Ex | 5,972 | .00 | 0 |
| 2017-02-27 | Phalen Michael P. (EVP & President, MedSurg) | Option Ex | 6,370 | .00 | 0 |
| 2017-02-27 | Pratt Timothy A. (EVP, GC & Chief Admin Officer) | Sale | 9,664 | 24.84 | 240,062 |
| 2017-02-27 | Pratt Timothy A. (EVP, GC & Chief Admin Officer) | Option Ex | 19,110 | .00 | 0 |
| 2017-02-24 | Butcher Arthur C (SVP&Pres, Endoscopy) | Option Ex | 1,338 | .00 | 0 |
| 2017-02-24 | Thepaut Eric Francis Yves (SVP & Pres, Europe) | Option Ex | 1,529 | .00 | 0 |
| 2017-02-24 | Sorenson John Bradley (SVP, Manuf & Sup Chn) | Option Ex | 1,529 | .00 | 0 |
| 2017-02-24 | Brennan Daniel J. (EVP and CFO) | Option Ex | 5,734 | .00 | 0 |
| 2017-02-24 | Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) | Option Ex | 2,485 | .00 | 0 |
| 2017-02-24 | Ballinger Kevin J. (SVP & Pres, Interven Cardio) | Option Ex | 2,867 | .00 | 0 |
| 2017-02-24 | Carruthers Wendy (SVP, Human Resources) | Option Ex | 2,485 | .00 | 0 |
| 2017-02-24 | Bose Supratim (EVP & President, Asia-Pacific) | Option Ex | 2,676 | .00 | 0 |
| 2017-02-24 | Mahoney Michael F (Chairman, President & CEO) | Option Ex | 29,052 | .00 | 0 |
| 2017-02-24 | Pierce David A (SVP and President, Endoscopy) | Option Ex | 3,058 | .00 | 0 |
| 2017-02-24 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 2,676 | .00 | 0 |
| 2017-02-24 | Dawkins Keith D (EVP, Global Chief Med. Off.) | Option Ex | 2,293 | .00 | 0 |
| 2017-02-24 | Fitzgerald Joseph Michael (EVP & President, CRM) | Option Ex | 4,778 | .00 | 0 |
| 2017-02-24 | Phalen Michael P. (EVP & President, MedSurg) | Option Ex | 3,440 | .00 | 0 |
| 2017-02-24 | Pratt Timothy A. (EVP, GC & Chief Admin Officer) | Option Ex | 4,587 | .00 | 0 |
| 2017-02-23 | Butcher Arthur C (SVP&Pres, Endoscopy) | Option Ex | 1,073 | .00 | 0 |
| 2017-02-23 | Mackey Edward F (EVP, Operations) | Option Ex | 2,299 | .00 | 0 |
| 2017-02-23 | Thepaut Eric Francis Yves (SVP & Pres, Europe) | Option Ex | 919 | .00 | 0 |
| 2017-02-23 | Sorenson John Bradley (SVP, Manuf & Sup Chn) | Option Ex | 1,533 | .00 | 0 |
| 2017-02-23 | Brennan Daniel J. (EVP and CFO) | Option Ex | 5,365 | .00 | 0 |
| 2017-02-23 | Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) | Option Ex | 2,146 | .00 | 0 |
| 2017-02-23 | Ballinger Kevin J. (SVP & Pres, Interven Cardio) | Option Ex | 3,678 | .00 | 0 |
| 2017-02-23 | Carruthers Wendy (SVP, Human Resources) | Option Ex | 2,452 | .00 | 0 |
| 2017-02-23 | Bose Supratim (EVP & President, Asia-Pacific) | Option Ex | 2,146 | .00 | 0 |
| 2017-02-23 | Mahoney Michael F (Chairman, President & CEO) | Option Ex | 23,758 | .00 | 0 |
| 2017-02-23 | Pierce David A (SVP and President, Endoscopy) | Option Ex | 2,452 | .00 | 0 |
| 2017-02-23 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 1,839 | .00 | 0 |
| 2017-02-23 | Dawkins Keith D (EVP, Global Chief Med. Off.) | Option Ex | 1,839 | .00 | 0 |
| 2017-02-23 | Fitzgerald Joseph Michael (EVP & President, CRM) | Option Ex | 4,138 | .00 | 0 |
| 2017-02-23 | Phalen Michael P. (EVP & President, MedSurg) | Option Ex | 2,452 | .00 | 0 |
| 2017-02-23 | Pratt Timothy A. (EVP, GC & Chief Admin Officer) | Option Ex | 3,678 | .00 | 0 |
| 2017-02-22 | Butcher Arthur C (SVP&Pres, Endoscopy) | Option Ex | 1,013 | .00 | 0 |
| 2017-02-22 | Mackey Edward F (EVP, Operations) | Option Ex | 2,896 | .00 | 0 |
| 2017-02-22 | Thepaut Eric Francis Yves (SVP & Pres, Europe) | Option Ex | 2,027 | .00 | 0 |
| 2017-02-22 | Sorenson John Bradley (SVP, Manuf & Sup Chn) | Option Ex | 1,593 | .00 | 0 |
| 2017-02-22 | Brennan Daniel J. (EVP and CFO) | Option Ex | 5,793 | .00 | 0 |
| 2017-02-22 | Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) | Option Ex | 2,317 | .00 | 0 |
| 2017-02-22 | Ballinger Kevin J. (SVP & Pres, Interven Cardio) | Option Ex | 3,765 | .00 | 0 |
| 2017-02-22 | Mahoney Michael F (Chairman, President & CEO) | Option Ex | 23,174 | .00 | 0 |
| 2017-02-22 | Pierce David A (SVP and President, Endoscopy) | Option Ex | 2,607 | .00 | 0 |
| 2017-02-22 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 1,882 | .00 | 0 |
| 2017-02-22 | Dawkins Keith D (EVP, Global Chief Med. Off.) | Option Ex | 1,738 | .00 | 0 |
| 2017-02-22 | Fitzgerald Joseph Michael (EVP & President, CRM) | Option Ex | 4,055 | .00 | 0 |
| 2017-02-22 | Phalen Michael P. (EVP & President, MedSurg) | Option Ex | 2,462 | .00 | 0 |
| 2017-02-22 | Pratt Timothy A. (EVP, GC & Chief Admin Officer) | Option Ex | 3,476 | .00 | 0 |
| 2017-02-07 | Dawkins Keith D (EVP, Global Chief Med. Off.) | Sale | 80,783 | 25.21 | 2,036,539 |
| 2017-02-06 | Thepaut Eric Francis Yves (SVP & Pres, Europe) | Sale | 23,775 | 24.94 | 592,853 |
| 2017-01-09 | Pierce David A (SVP and President, Endoscopy) | Sale | 10,232 | 22.24 | 227,549 |
| 2017-01-09 | Pratt Timothy A. (EVP, GC & Chief Admin Officer) | Sale | 6,195 | 22.24 | 137,770 |
| 2017-01-03 | Bose Supratim (EVP & President, Asia-Pacific) | Option Ex | 14,926 | .00 | 0 |
| 2017-01-01 | Brennan Daniel J. (EVP and CFO) | Option Ex | 29,185 | .00 | 0 |
| 2017-01-01 | Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) | Option Ex | 12,646 | .00 | 0 |
| 2017-01-01 | Ballinger Kevin J. (SVP & Pres, Interven Cardio) | Option Ex | 29,184 | .00 | 0 |
| 2017-01-01 | Carruthers Wendy (SVP, Human Resources) | Option Ex | 12,646 | .00 | 0 |
| 2017-01-01 | Bose Supratim (EVP & President, Asia-Pacific) | Option Ex | 27,238 | .00 | 0 |
| 2017-01-01 | Mahoney Michael F (President & CEO) | Option Ex | 147,873 | .00 | 0 |
| 2017-01-01 | Pierce David A (SVP and President, Endoscopy) | Option Ex | 15,565 | .00 | 0 |
| 2017-01-01 | Nanavaty Maulik (SVP & Pres, Neuromodulation) | Option Ex | 13,619 | .00 | 0 |
| 2017-01-01 | Dawkins Keith D (EVP, Global Chief Med. Off.) | Option Ex | 11,673 | .00 | 0 |
| 2017-01-01 | Fitzgerald Joseph Michael (EVP & President, CRM) | Option Ex | 24,321 | .00 | 0 |
| 2017-01-01 | Phalen Michael P. (EVP & President, MedSurg) | Option Ex | 17,510 | .00 | 0 |
| 2017-01-01 | Pratt Timothy A. (EVP, GC & Chief Admin Officer) | Option Ex | 23,347 | .00 | 0 |
| 2016-11-01 | Mahoney Michael F (President & CEO) | Option Ex | 341,670 | .00 | 0 |
| 2016-11-01 | Pratt Timothy A. (EVP, GC & Chief Admin Officer) | Sale | 24,752 | 21.89 | 541,821 |
| 2016-11-01 | Pratt Timothy A. (EVP, GC & Chief Admin Officer) | Option Ex | 17,000 | 13.56 | 230,520 |
| 2016-10-29 | Thepaut Eric Francis Yves (SVP & Pres, Europe) | Option Ex | 1,696 | .00 | 0 |
| 2016-10-25 | Thepaut Eric Francis Yves (SVP & Pres, Europe) | Option Ex | 3,690 | .00 | 0 |
| 2016-10-03 | Pratt Timothy A. (EVP, GC & Chief Admin Officer) | Sale | 24,000 | 23.54 | 564,960 |
| 2016-10-03 | Pratt Timothy A. (EVP, GC & Chief Admin Officer) | Option Ex | 17,000 | 13.56 | 230,520 |
| 2016-09-01 | Pratt Timothy A. (EVP, GC & Chief Admin Officer) | Sale | 24,074 | 24.09 | 580,063 |
| 2016-09-01 | Pratt Timothy A. (EVP, GC & Chief Admin Officer) | Option Ex | 17,000 | 13.56 | 230,520 |
| 2016-08-11 | Sorenson John Bradley (SVP, Manuf & Sup Chn) | Sale | 2,500 | 23.90 | 59,750 |
| 2016-08-01 | Mahoney Michael F (President & CEO) | Sale | 44,400 | 24.44 | 1,085,002 |
| 2016-08-01 | Pratt Timothy A. (EVP, GC & Chief Admin Officer) | Sale | 24,000 | 24.46 | 586,968 |
| 2016-08-01 | Pratt Timothy A. (EVP, GC & Chief Admin Officer) | Option Ex | 17,000 | 13.56 | 230,520 |
| 2016-07-20 | Ballinger Kevin J. (SVP & Pres, Interven Cardio) | Sale | 78,122 | 24.03 | 1,877,271 |
| 2016-07-20 | Ballinger Kevin J. (SVP & Pres, Interven Cardio) | Option Ex | 78,122 | 6.31 | 492,949 |
| 2016-07-20 | Pierce David A (SVP and President, Endoscopy) | Sale | 2,480 | 24.03 | 59,594 |
| 2016-07-20 | Pierce David A (SVP and President, Endoscopy) | Option Ex | 2,480 | 10.70 | 26,536 |
| 2016-07-20 | Phalen Michael P. (EVP & President, MedSurg) | Sale | 35,000 | 24.03 | 841,050 |
| 2016-07-20 | Phalen Michael P. (EVP & President, MedSurg) | Option Ex | 35,000 | 12.52 | 438,200 |
| 2016-07-01 | Mahoney Michael F (President & CEO) | Sale | 100,000 | 23.43 | 2,342,600 |
| 2016-07-01 | Pratt Timothy A. (EVP, GC & Chief Admin Officer) | Sale | 24,000 | 23.39 | 561,432 |
| 2016-07-01 | Pratt Timothy A. (EVP, GC & Chief Admin Officer) | Option Ex | 17,000 | 13.56 | 230,520 |
| 2016-06-01 | Mahoney Michael F (President & CEO) | Sale | 100,000 | 22.69 | 2,268,700 |
| 2016-06-01 | Pratt Timothy A. (EVP, GC & Chief Admin Officer) | Sale | 24,229 | 22.66 | 548,980 |
| 2016-06-01 | Pratt Timothy A. (EVP, GC & Chief Admin Officer) | Option Ex | 17,000 | 13.56 | 230,520 |
| 2016-05-10 | Dawkins Keith D (EVP, Global Chief Med. Off.) | Sale | 80,000 | 22.15 | 1,772,240 |
| 2016-05-06 | Mirviss Jeffrey B. (SVP&Pres, Periph Intervent) | Sale | 24,659 | 21.94 | 541,043 |
| 2016-05-02 | Mahoney Michael F (President & CEO) | Sale | 100,000 | 22.12 | 2,212,300 |
| 2016-05-02 | Pratt Timothy A. (EVP, GC & Chief Admin Officer) | Sale | 24,000 | 21.93 | 526,440 |
| 2016-05-02 | Pratt Timothy A. (EVP, GC & Chief Admin Officer) | Option Ex | 17,000 | 13.56 | 230,520 |
| 2016-04-27 | Ballinger Kevin J. (SVP & Pres, Interven Cardio) | Sale | 111,807 | 21.62 | 2,416,820 |
| 2016-04-27 | Ballinger Kevin J. (SVP & Pres, Interven Cardio) | Option Ex | 111,807 | 9.83 | 1,099,398 |
Insider trading activities including stock purchases, stock sales, and option exercises
of BSX listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Boston Scientific Corp (symbol BSX,
CIK number 885725) see
the Securities and Exchange Commission (SEC) website.